Indeed, the proteoglycan glypican-1 (GPC1) and the tumor antigen chondroitin sulfate proteoglycan 4 (CSPG4) were detected in tumor exosomes from heterogeneous samples of pancreatic cancer [155] or melanoma [156], respectively. This evidence concerns the gene GPC1 and pancreatic neoplasm.